Date published: 
22 March 2018
Type: 
News
Intended audience: 
Health professionals

There is currently a shortage of the adult formulation of Engerix-B® available to Australia. The shortage has impacted on private market supply.

Supply for the National Immunisation Program (NIP) has not been affected at this time, so vaccination using the adult formulation of hepatitis B vaccines should continue as scheduled for eligible individuals. 

Please refer to the document below which provides clinical advice to assist in using alternate hepatitis B vaccines during supply shortages.

ATAGI advice (updated): alternatives during supply shortage of adult hepatitis B vaccines